Advertisement

Picture biomindz Brand LSG Mainz Place to Biotech LI 650x100px
Document › Details

Symrise AG. (5/6/19). "Press Release: Symrise Acquires Italian Biotech Company Cutech. Adds Competitive Edge in Bio-analytical Methods – Expands R&D Capacities for the Efficacy Testing of Cosmetic Ingredients".

Organisations Organisation Symrise AG
  Group Symrise (Group)
  Organisation 2 Cutech S.r.l.
  Group Symrise (Group)
Products Product preclinical research
  Product 2 cosmetics
Index term Index term Cutech (IT)–Symrise: investment, 201905 acquisition of Cutech Srl by Symrise
Persons Person Schmaus, Gerhard (Symrise 201905 Head of Global Innovation Cosmetic Ingredients Division)
  Person 2 Pertile, Paolo (Cutech 201905 CEO + Co-Founder)
     


– Accelerates the development of active ingredients based on predictive ex vivo models

– Unique pre-clinical screening services provided to the cosmetic industry


Symrise has signed a contract to acquire the Italian biotech company Cutech in Padua. The enterprise offers unique pre-clinical screening services for cosmetic ingredients and finished formulations. The purchase will expand the expertise of Symrise in the efficacy testing of cosmetic ingredients and open new opportunities for collaboration with partners from scientific institutions. It will also increase the go-to-market speed for novel active ingredients.

“Cutech constitutes the perfect fit for Symrise’s Cosmetic Ingredients Division. The highly specific R&D and biotechnology capabilities of Cutech optimally complement the research expertise of Symrise”, says Dr. Gerhard Schmaus, Head of Global Innovation Cosmetic Ingredients Division at Symrise.

“We have decided to closer collaborate with Symrise as both partners can benefit from the union. Symrise acquires considerable know-how in the prediction of the effectiveness of cosmetic ingredients. Cutech will benefit from the broad research base at Symrise and its technological resources. This will lead to a faster development of effective cosmetic ingredients. We look forward with excitement to our joint projects,” says Dr. Paolo Pertile, CEO at Cutech.

The biotech company, founded in 2002, specializes in unique pre-clinical screening services based on innovative proprietary ex vivo skin, sebaceous gland and hair models. Cutech also contributes IP on natural ingredients, such as micro algae to supplement the Symrise portfolio.

“The joining forces of Symrise and Cutech will make the development of new proprietary analysis and prediction models for cosmetic ingredients easier and faster. Such models will strengthen the leadership of Symrise Cosmetics Ingredients and will position it one step ahead of the competition”, concludes Eder Ramos, President Cosmetic Ingredient Division. “For our customers, adding pre-clinical testing to our service portfolio will definitely constitute a plus during their product development. In addition it will also enable us to further expand our biotech network, thus accessing new, cutting-edge technologies.”

Deloitte Financial Advisory S.r.l. is acting as financial advisor to Symrise. Clifford Chance is acting as legal advisor to Symrise. Pirola Pennuto Zei & Associati is acting as legal advisor to Cutech.

   
Record changed: 2023-06-05

Advertisement

Picture biomindz TRON LSG Mainz Translation Cancer Immunotherapy 650x200px

More documents for Symrise (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture biomindz Mainz Biomed LSG Colorectal Cancer Screening 650x300px




» top